There were 1,880 press releases posted in the last 24 hours and 439,451 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image